Hydroxychloroquine, an anti-malarial drug, is being used to treat healthcare workers handling coronavirus cases. The government had on Mar 25 banned the export of hydroxychloroquine and its formulations, but had allowed shipments from units in special economic zones, export-oriented units and those made to fulfil obligation under advance licensing. The export of hydroxychloroquine and its formulations will remain prohibited, without any exception, the Director General of Foreign Trade said on Saturday in an amendment to its earlier notification.
India bans export of hydroxychloroquine
The Indian government has imposed a complete ban on export of hydroxychloroquine and its formulations, including those from export-oriented units, in view of the coronavirus outbreak.
RECENT STORIES
Sensex Jumps 447 Points, Nifty Gains 153 After RBI’s 25 bps Cut, Markets Cheer Softer Inflation...
SEBI Bans Financial Influencer Avadhut Sathe From Stock Markets, Freezes His Accounts & Orders To...
RBI’s ₹1 Lakh Crore Bond Buying and $5 Billion Swap, What It Means For Markets & The Common Man...
Industry Leaders Across Sectors Welcomed RBI's 5.25% Repo Rate Cut, Strengthening India’s...
Biomass Manufacturing Facility Set Up With The Support Of Talwandi Sabo Power Helped In Reducing...